Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;34(5):853-868.
doi: 10.1111/pcmr.12945. Epub 2020 Nov 20.

Connexins in melanoma: Potential role of Cx46 in its aggressiveness

Affiliations
Review

Connexins in melanoma: Potential role of Cx46 in its aggressiveness

Viviana P Orellana et al. Pigment Cell Melanoma Res. 2021 Sep.

Abstract

Melanoma is the most aggressive skin cancer, and in metastatic advanced states, it is completely refractory to chemotherapy. Therefore, it is relevant to understand the molecular bases that rule their aggressiveness. Connexins (Cxs) are proteins that under normal physiological conditions participate in intercellular communication, via the exchange of signaling molecules between the cytoplasm and extracellular milieu and the exchange of ions/second messengers between the cytoplasm of contacting cells. These proteins have shown important roles in cancer progression, chemo- and radiotherapy resistance, and metastasis. Accordingly, Cx26 and Cx43 seem to play important roles in melanoma progression and metastasis. On the other hand, Cx46 is typically expressed in the eye lens, where it seems to be associated with oxidative stress protection in fiber lens cells. However, in the last decade, Cx46 expression has been associated with breast and brain cancers, due to its role in potentiation of both extracellular vesicle release and cancer stem cell-like properties. In this review, we analyzed a potential role of Cx46 as a new biomarker and therapeutic target in melanoma.

Keywords: Cx46; connexins; gap junctions; melanocytes; melanoma; skin.

PubMed Disclaimer

References

REFERENCES

    1. Aasen, T., Leithe, E., Graham, S. V., Kameritsch, P., Mayán, M. D., Mesnil, M., Pogoda, K., & Tabernero, A. (2019). Connexins in cancer: bridging the gap to the clinic. Oncogene, 38(23), 4429-4451. https://doi.org/10.1038/s41388-019-0741-6
    1. Ableser, M. J., Penuela, S., Lee, J., Shao, Q., & Laird, D. W. (2014). Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo. Journal of Biological Chemistry, 289(3), 1592-1603. https://doi.org/10.1074/jbc.M113.507228
    1. Acuña, R. A., Varas-Godoy, M., Berthoud, V. M., Alfaro, I. E., & Retamal, M. A. (2020). Connexin-46 contained in extracellular vesicles enhance malignancy features in breast cancer cells. Biomolecules, 10(5), 676. https://doi.org/10.3390/biom10050676
    1. Alaga, K. C., Crawford, M., Dagnino, L., & Laird, D. W. (2017). Aberrant Cx43 expression and mislocalization in metastatic human melanomas. Journal of Cancer, 8(7), 1123-1128. https://doi.org/10.7150/jca.18569
    1. Andor, N., Graham, T. A., Jansen, M., Xia, L. C., Aktipis, C. A., Petritsch, C., Ji, H. P., & Maley, C. C. (2016). Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nature Medicine, 22(1), 105-113. https://doi.org/10.1038/nm.3984

Publication types

LinkOut - more resources